The effect of antenatal Betamethasone on preventionofneonatal respiratory distress syndrome before elective cesarean section at term

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20121224011862N3

Enrollment

200

Registered

2019-06-22

Start date

2019-06-23

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Intervention group: intramuscular injection of 12 mg betamethasone (manufactured in Iran) in two doses between 24 hours. Intervention 2: Control group: Group without receive betamethas

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women with single pregnancy Gestational age greater than 37 weeks maternal cesarean section indications only because of repetitive C/S.

Exclusion criteria

Exclusion criteria: multiple pregnancies fetus with major congenital anomalies Oligohydroamnios Polyhydramnios

Design outcomes

Primary

Measure	Time frame
Respiratory distress syndrome in the baby after birth. Timepoint: Every half hour until 48 hours after birth. Method of measurement: Physical examination.	—

Secondary

Measure	Time frame
The need for admission to the neonatal intensive care unit. Timepoint: From birth to discharge. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Sahaf

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 35519161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026